Navigation Links
China-Biotics, Inc. Applies for Four Patents on Probiotic Formulations
Date:7/31/2009

SHANGHAI, July 31 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT) ("China-Biotics", "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced it has submitted applications for four patents to the State Intellectual Property Office of the People's Republic of China.

These applications are patents for a protein powder formulation; home yogurt fermentation, a retail powder that enables customers to make yogurt at home; a yogurt powder; and a health-enhancing yogurt. All of these applications are for probiotics-based products. Currently, the Intellectual Property Office is conducting an official review of these applications. It takes about two years to obtain patent certificates under normal circumstances.

"These four new formulations are the result of sustained product development by our highly skilled staff of more than 30 researchers with advanced degrees and our extensive relationships with academic institutions," said Mr. Jinan Song, Chairman and Chief Executive Officer of China-Biotics.

The Company also announced that Mr. Zhenjia Bian and Mr. Chengdong Yi, senior officials from the State Food and Drug Administration, visited the Company recently. The visit coincided with China's new umbrella food safety law, which sets more stringent standards for food production throughout China. The officials praised the Company's significant achievements in probiotics applications during the past decade and encouraged management to continue its business expansion efforts.

About China-Biotics, Inc.

China-Biotics, Inc. ("China-Biotics," "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing
'/>"/>

SOURCE China-Biotics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results
2. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2009 Financial Results
3. China-Biotics, Inc. to Join Russell 3000 Index
4. China-Biotics, Inc. to Attend Digestive Disease Week 2009
5. China-Biotics, Inc. to Present at CCG Investor Relations China Rising Conference
6. China-Biotics, Inc. Supplies Probiotics as Additive for Poultry Feed
7. China-Biotics, Inc. Appoints New Chief Financial Officer
8. China-Biotics, Inc. to Present at Roth Capital Partners 21st Annual OC Growth Stock Conference
9. China-Biotics, Inc. Receives Manufacturing Certificate for New Products
10. China-Biotics, Inc. Reports Second Quarter 2009 Financial Results
11. China-Biotics, Inc. Retains KPMG for the Implementation of Sarbanes-Oxley Act Section 404

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... Md., Nov. 19 Spherix In...chnology for diabetes therapy, and a provider of t...d, supplement, biotechnology and pharmaceutical co...reported $6.3 million registered direct placement ...its common stock and warrants to purchase up to 1,...
(Date:11/19/2009)...9 Spherix Incorporated (... diabetes therapy, and a provider of technical and...t, biotechnology and pharmaceutical companies, tod...ng of Shareholders. ,, At the meeting, sharehol...ted the following members to the Board of Director...
(Date:11/19/2009)...ny, November 19 MONITORING FORCE G...h, 2009 Flibanserin in the,indication treatment-re...disease for orphan drug status designation with th...ed dyskinesia is a complication of the mainstay,tr...en to some of those,affected, since it may be disa...
(Date:11/19/2009)...SIK surgeons and recognized refractive and catarac... made brought their fellow surgeons up-to-date on ...ry, cataract surgery, and ophthalmology in general...thalmology (AAO) annual meeting in San Francisco, ...ber, Dr. David Huang, MD, Dr. Randy Epstein, Dr. W...
Breaking Biology Technology:Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9
...f, cells from pigs are to be used in clinical tria...betes, MINNEAPOLIS, July 29 The Lions Clubs of M...ommitment to support Spring Point,Project, a Minne...he,affordable and widespread availability of pig d... http://www.newscom.com/cgi-bin/prnh/20071214/CLF0...
...ar Equity, LLC issues a review of,VioQuest Pharmac..., "510k,Application Submitted for Xyfid(TM) and Pr...stones and Share Price Appreciation.", This revie...ity.com ., VioQuest Pharmaceuticals is a New Jers...ng a recognized leader in the successful developme...
...29 Zenobia Therapeutics, Inc.,(Zenobia) announced...ment,Initiative award from The Michael J. Fox Foun...ts industry-based research with potential to,funda...PD) treatment. In,collaboration with Dr. Christoph...iscover and develop compounds that block the activ...
Other Biology Technology:Spring Point Project Gains Support of Lions Clubs 2Spring Point Project Gains Support of Lions Clubs 3VioQuest Pharmaceuticals, Inc Valuation Upgrade Review Issued By Scimitar Equity, LLC 2Zenobia Therapeutics, Inc. Receives Michael J. Fox Foundation for Parkinson's Research Award for Work on PD-implicated Protein LRRK2 2
(Date:11/20/2009)... Toxic dust: Toxins in coal-tar-based sealcoats ... house dust, according to a USGS study. PAHs or ...les found in oil, coal and tar deposits, and can h...are often found in house dust; however, the specif... Researchers found that dust from indoor areas nea...
(Date:11/20/2009)...s release is available in German . , In the...Investigation , Dr. Stefanie Eyerich and Dr. Kilia...rial College London and Istituto Dermopatico dell,...iscovery. It represents a milestone on the way to ...skin diseases such as psoriasis and allergic react...
(Date:11/20/2009)...gh University,s Energy Research Center (ERC) has b...ergy (DOE) to develop methods of recovering and re...on-dioxide (CO 2 ) compression process in a carbon...is to facilitate carbon capture and sequestration,... 2 , a greenhouse gas, emitted into the atmosphere...
Breaking Biology News(10 mins):From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5Discovery of new type of immune cells regulating inflammation in chronic diseases 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Nile Therapeutics Inc To Raise 243 4 Million in Private Placement 12937 1Nile Therapeutics Inc To Raise 243 4 Million in Private Placement 12937 2Nile Therapeutics Inc To Raise 243 4 Million in Private Placement 12937 3Nile Therapeutics Inc To Raise 243 4 Million in Private Placement 12937 4Funxional Successfully Completes Initial Clinical Trial of FX125L an Anti Inflammatory Drug With a Novel Mechanism of Action 12935 1Funxional Successfully Completes Initial Clinical Trial of FX125L an Anti Inflammatory Drug With a Novel Mechanism of Action 12935 2Meatless Burgers Hot Dogs Not Always Full of Veggies 51049 1Meatless Burgers Hot Dogs Not Always Full of Veggies 51049 2
...in the Health Care Industry, SAN JOSE, Calif., No...NUF), a leading biometric and security solutions,p...ith Hong Kong,Polytechnic University Clinic for th...red by Titanium,s Biometric Facial Recognition tec...atients, together with their,corresponding medical...
...ed Nations Climate Change Conference in Bali, Indo...tion and the critical role that remote sensing sys... Emissions from Deforestation and Degradation) mec...t nations for avoiding deforestation. Using synthe...week period by the Japanese Advanced Land Observin...
...stin has received $1.9 million to expand a compute...isions about placement of devices to detect nuclea...meland Security provided the funds to improve the ...in Russia and other countries of the former Soviet...tores of nuclear weapons material and radioactive ...
Other Biology News:Titanium Group Announces Biometric Contract with One of the Most Active Clinics in Hong Kong 2Titanium Group Announces Biometric Contract with One of the Most Active Clinics in Hong Kong 3Woods Hole Research Center debuts new image mosaic that will strengthen global forest monitoring 2Woods Hole Research Center debuts new image mosaic that will strengthen global forest monitoring 3Improving detection of nuclear smuggling goal of computer model of mechanical engineer 2Improving detection of nuclear smuggling goal of computer model of mechanical engineer 3
..., the Moticam 2300 camera (MC2300) attaches to vir...e, or trinocular port. Included in the standard pa...ML software offers quick and accurate image captur...ution for examination or documentation purposes. T...
Mouse Anti-Human PPP2R2C Monoclonal Antibody, Unconjugated, Clone 6D1 from Novus Biologicals
96-well 0.2 ml PCR Plate Caps, 300 from Bio-Rad
PROTEIN G PLUS AGAROSE from Pierce Biotechnology, Inc.
Biology Products: